1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model

BACKGROUND: Pneumocystis pneumonia (PCP) is an opportunistic fungal infection that affects immunocompromised patients. Ibrexafungerp (IBX) is an oral and intravenous antifungal from a novel class of glucan synthase inhibitors, triterpenoids, and has shown activity against Candida, Aspergillus, and P...

Descripción completa

Detalles Bibliográficos
Autores principales: Borroto-Esoda, Katyna, Azie, Nkechi, Ashbaugh, Alan, Cushion, Melanie, Angulo, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776520/
http://dx.doi.org/10.1093/ofid/ofaa439.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776520/
http://dx.doi.org/10.1093/ofid/ofaa439.1435

Ejemplares similares